BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19090767)

  • 1. Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy.
    Li YH; Yang P; Kong WJ; Wang YX; Hu CQ; Zuo ZY; Wang YM; Gao H; Gao LM; Feng YC; Du NN; Liu Y; Song DQ; Jiang JD
    J Med Chem; 2009 Jan; 52(2):492-501. PubMed ID: 19090767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of berberine analogues as a novel class of low-density-lipoprotein receptor up-regulators.
    Yang P; Song DQ; Li YH; Kong WJ; Wang YX; Gao LM; Liu SY; Cao RQ; Jiang JD
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4675-7. PubMed ID: 18644725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor.
    Wang YX; Wang YP; Zhang H; Kong WJ; Li YH; Liu F; Gao RM; Liu T; Jiang JD; Song DQ
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6004-8. PubMed ID: 19800225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of simvastatin with berberine improves the lipid-lowering efficacy.
    Kong WJ; Wei J; Zuo ZY; Wang YM; Song DQ; You XF; Zhao LX; Pan HN; Jiang JD
    Metabolism; 2008 Aug; 57(8):1029-37. PubMed ID: 18640378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationship of berberine analogues in LDLR up-regulation and AMPK activation.
    Wang YX; Kong WJ; Li YH; Tang S; Li Z; Li YB; Shan YQ; Bi CW; Jiang JD; Song DQ
    Bioorg Med Chem; 2012 Nov; 20(22):6552-8. PubMed ID: 23058107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.
    Kong W; Wei J; Abidi P; Lin M; Inaba S; Li C; Wang Y; Wang Z; Si S; Pan H; Wang S; Wu J; Wang Y; Li Z; Liu J; Jiang JD
    Nat Med; 2004 Dec; 10(12):1344-51. PubMed ID: 15531889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine.
    Abidi P; Zhou Y; Jiang JD; Liu J
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2170-6. PubMed ID: 16100034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.
    Li YH; Li Y; Yang P; Kong WJ; You XF; Ren G; Deng HB; Wang YM; Wang YX; Jiang JD; Song DQ
    Bioorg Med Chem; 2010 Sep; 18(17):6422-8. PubMed ID: 20673726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel class of antihyperlipidemic agents with low density lipoprotein receptor up-regulation via the adaptor protein autosomal recessive hypercholesterolemia.
    Asano S; Ban H; Tsuboya N; Uno S; Kino K; Ioriya K; Kitano M; Ueno Y
    J Med Chem; 2010 Apr; 53(8):3284-95. PubMed ID: 20356098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New low-density lipoprotein receptor upregulators acting via a novel mechanism.
    Ashton MJ; Brown TJ; Fenton G; Halley F; Harper MF; Lockey PM; Porter B; Roach AG; Stuttle KA; Vicker N; Walsh RJ
    J Med Chem; 1996 Aug; 39(17):3343-56. PubMed ID: 8765518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
    Evans MJ; Mahaney PE; Borges-Marcucci L; Lai K; Wang S; Krueger JA; Gardell SJ; Huard C; Martinez R; Vlasuk GP; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G543-52. PubMed ID: 19136377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of N-(4-amino-2,6-diisopropylphenyl)-N'-(1,4-diarylpiperidine-4-yl)methylureas as anti-hyperlipidemic agents.
    Asano S; Ban H; Kino K; Ioriya K; Muraoka M
    Bioorg Med Chem; 2009 Jul; 17(13):4636-46. PubMed ID: 19464189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raisins and walking alter appetite hormones and plasma lipids by modifications in lipoprotein metabolism and up-regulation of the low-density lipoprotein receptor.
    Puglisi MJ; Mutungi G; Brun PJ; McGrane MM; Labonte C; Volek JS; Fernandez ML
    Metabolism; 2009 Jan; 58(1):120-8. PubMed ID: 19059539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage.
    Li K; Yao W; Zheng X; Liao K
    Cell Res; 2009 Aug; 19(8):1006-17. PubMed ID: 19546885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of low-density lipoprotein receptor in human hepatocytes is induced by sequestration of free cholesterol in the endosomal/lysosomal compartment.
    Issandou M; Guillard R; Boullay AB; Linhart V; Lopez-Perez E
    Biochem Pharmacol; 2004 Jun; 67(12):2281-9. PubMed ID: 15163559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 1,4-diarylpiperidine-4-methylureas as anti-hyperlipidemic agents: dual effectors on acyl-CoA:cholesterol O-acyltransferase and low-density lipoprotein receptor expression.
    Asano S; Ban H; Kino K; Ioriya K; Muraoka M
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1062-5. PubMed ID: 19167888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity studies of novel orally active non-terpenoic 2,3-oxidosqualene cyclase inhibitors.
    Dehmlow H; Aebi JD; Jolidon S; Ji YH; von der Mark EM; Himber J; Morand OH
    J Med Chem; 2003 Jul; 46(15):3354-70. PubMed ID: 12852766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Berberine with Resveratrol Improves the Lipid-Lowering Efficacy.
    Zhu X; Yang J; Zhu W; Yin X; Yang B; Wei Y; Guo X
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
    Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant and cytotoxic activities of canadine: biological effects and structural aspects.
    Correché ER; Andujar SA; Kurdelas RR; Gómez Lechón MJ; Freile ML; Enriz RD
    Bioorg Med Chem; 2008 Apr; 16(7):3641-51. PubMed ID: 18295494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.